INS and obesity disorder: In obesity, the imbalance of endocannabinoid peripheral signaling also depends on a reduction in FAAH metabolites, which impacts visceral fat, leading to CB1R overstimulation and subsequent adiponectin inhibition, resulting in the exacerbation of insulin resistance and low-grade inflammation [288,295].